©The Author(s) 2025.
World J Transplant. Dec 18, 2025; 15(4): 106938
Published online Dec 18, 2025. doi: 10.5500/wjt.v15.i4.106938
Published online Dec 18, 2025. doi: 10.5500/wjt.v15.i4.106938
Table 3 Laboratory values before and at three months after liver transplantation, n (%)
| Value | Full cohort (n = 79) | Recurrent AILD (n = 21) | Non-recurrent AILD (n = 58) | Odds ratio (95%CI) | P value |
| Before LT | |||||
| TB (mg/dL) (mean ± SD) | 11.67 ± 12.38 | 15.49 ± 12.95 | 10.28 ± 11.99 | 1.03 (0.99-1.07) | 0.108 |
| Direct bilirubin (mg/dL) (mean ± SD) | 6.59 ± 7.39 | 8.70 ± 7.12 | 5.83 ± 7.40 | 1.04 (0.98-1.11) | 0.137 |
| Indirect bilirubin (mg/dL) (mean ± SD) | 5.07 ± 5.34 | 6.80 ± 6.06 | 4.45 ± 4.96 | 1.07 (0.98-1.17) | 0.099 |
| ALT (U/L) (mean ± SD) | 98.94 ± 132.33 | 136.94 ± 184.39 | 85.19 ± 106.34 | 1.00 (0.99-1.00) | 0.147 |
| AST (U/L) (mean ± SD) | 144.35 ± 161.63 | 171.43 ± 177.24 | 134.54 ± 156.08 | 1.00 (0.99-1.00) | 0.378 |
| AST/ALT (mean ± SD) | 1.83 ± 0.72 | 1.62 ± 0.64 | 1.91 ± 0.73 | 0.50 (0.21-1.20) | 0.123 |
| Alkaline phosphatase (U/L) (mean ± SD) | 285.24 ± 199.90 | 326.67 ± 254.21 | 270.24 ± 176.48 | 1.00 (0.99-1.00) | 0.272 |
| Total proteins (g/dL) (mean ± SD) | 6.41 ± 1.20 | 6.35 ± 1.56 | 6.43 ± 1.05 | 0.94 (0.61-1.43) | 0.782 |
| ALB (g/dL) (mean ± SD) | 2.89 ± 0.66 | 2.70 ± 0.62 | 2.95 ± 0.67 | 0.53 (0.24-1.19) | 0.128 |
| Globulin (g/dL) (mean ± SD) | 3.52 ± 1.36 | 3.65 ± 1.90 | 3.47 ± 1.12 | 1.09 (0.76-1.57) | 0.611 |
| ALB/globulin ratio (mean ± SD) | 1.01 ± 0.60 | 1.01 ± 0.66 | 1.01 ± 0.59 | 1.01 (0.44-2.31) | 0.981 |
| Total leukocyte count (× 103/μL) (mean ± SD) | 5.35 ± 3.35 | 5.47 ± 3.07 | 5.31 ± 3.47 | 1.01 (0.87-1.17) | 0.848 |
| ALC (× 103/μL) (mean ± SD) | 0.82 ± 0.62 | 0.71 ± 0.46 | 0.86 ± 0.67 | 0.64 (0.26-1.59) | 0.341 |
| ANC (mean ± SD) | 3.88 ± 3.05 | 4.12 ± 2.79 | 3.79 ± 3.16 | 1.03 (0.88-1.21) | 0.669 |
| TB > 3 (mg/dL) | 61 (77.2) | 42 (72.4) | 19 (90.5) | 3.61 (0.75-17.33) | 0.108 |
| ALT > 2 (ULN) | 30 (37.9) | 18 (31) | 12 (57.1) | 2.96 (1.06-8.28) | 0.038 |
| AST > 2 (ULN) | 50 (63.2) | 34 (58.6) | 16 (76.2) | 2.25 (0.72-7.00) | 0.158 |
| Three months after LT | |||||
| TB (mg/dL) (mean ± SD) | 1.08 ± 2.56 | 1.65 ± 4.63 | 0.84 ± 0.82 | 1.12 (0.89-1.41) | 0.319 |
| ALT (U/L) (mean ± SD) | 61.45 ± 179.98 | 51.47 ± 105.78 | 65.47 ± 203.19 | 0.99 (0.99-1.00) | 0.765 |
| AST (U/L) (mean ± SD) | 41.25 ± 113.26 | 35.46 ± 67.48 | 43.59 ± 127.69 | 0.99 (0.99-1.00) | 0.783 |
| ALB (g/dL) (mean ± SD) | 4.13 ± 0.50 | 4.17 ± 0.33 | 4.11 ± 0.56 | 1.29 (0.44-3.77) | 0.632 |
| Creatinine (mg/dL) (mean ± SD) | 0.90 ± 0.25 | 0.90 ± 0.21 | 0.90 ± 0.27 | 1.03 (0.13-7.70) | 0.972 |
| Total leukocyte count (× 103/μL) (mean ± SD) | 4.47 ± 1.64 | 4.60 ± 1.42 | 4.42 ± 1.73 | 1.06 (0.78-1.45) | 0.683 |
| ALC (× 103/mL) (mean ± SD) | 1.13 ± 0.73 | 0.94 ± 0.43 | 1.21 ± 0.80 | 0.50 (0.19-1.26) | 0.146 |
| ANC (mean ± SD) | 2.76 ± 1.18 | 3.05 ± 1.01 | 2.65 ± 1.23 | 1.33 (0.86- 2.07) | 0.197 |
- Citation: Salgado-de la Mora M, Mendez-Guerrero O, Torre A, Vilatoba M, Castro Narro GE, Lumbreras Márquez MI, Navarro-Alvarez N. Risk factors for autoimmune liver disease recurrence after liver transplantation. World J Transplant 2025; 15(4): 106938
- URL: https://www.wjgnet.com/2220-3230/full/v15/i4/106938.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i4.106938